Cerca pubblicazione

Via Vittorio Alfieri,17
Torino (Italy)

SEGUICI

CONTATTI

+39011.76.51.239
info@adreshe.com

A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving  two or more lines of systemic therapy

Bellone M, Sabinot A, D’Arpino A, et al. Glob Reg Health Technol Assess 2024; 11: 239-47